| Analysis | Metabolite Name | Measured Value | Units | Treatment |
|---|---|---|---|---|
| ESI/Orbitrap Negative ion mode | Arachidonic Acid (20:4) | 19.4 | Peak area | Diagnosis -No treatment |
| ESI/Orbitrap Negative ion mode | Arachidonic Acid (20:4) | 24.1 | Peak area | Diagnosis -No treatment |
| ESI/Orbitrap Negative ion mode | Arachidonic Acid (20:4) | 26.9 | Peak area | Diagnosis -No treatment |
| ESI/Orbitrap Negative ion mode | Arachidonic Acid (20:4) | 33.8 | Peak area | Diagnosis -No treatment |
| ESI/Orbitrap Negative ion mode | Arachidonic Acid (20:4) | 37 | Peak area | Post remission |
| ESI/Orbitrap Negative ion mode | Arachidonic Acid (20:4) | 44.5 | Peak area | Diagnosis -No treatment |
| ESI/Orbitrap Negative ion mode | Arachidonic Acid (20:4) | 45.7 | Peak area | Post remission |
| ESI/Orbitrap Negative ion mode | Arachidonic Acid (20:4) | 49.6 | Peak area | Diagnosis -No treatment |
| ESI/Orbitrap Negative ion mode | Arachidonic Acid (20:4) | 52.1 | Peak area | Post remission |
| ESI/Orbitrap Negative ion mode | Arachidonic Acid (20:4) | 57.3 | Peak area | Diagnosis -No treatment |
| ESI/Orbitrap Negative ion mode | Arachidonic Acid (20:4) | 58.8 | Peak area | Diagnosis -No treatment |
| ESI/Orbitrap Negative ion mode | Arachidonic Acid (20:4) | 67.8 | Peak area | Post remission |
| ESI/Orbitrap Negative ion mode | Arachidonic Acid (20:4) | 69.1 | Peak area | Diagnosis -No treatment |
| ESI/Orbitrap Negative ion mode | Arachidonic Acid (20:4) | 72.5 | Peak area | Diagnosis -No treatment |
| ESI/Orbitrap Negative ion mode | Arachidonic Acid (20:4) | 77.6 | Peak area | Diagnosis -No treatment |
| ESI/Orbitrap Negative ion mode | Arachidonic Acid (20:4) | 79.1 | Peak area | Diagnosis -No treatment |
| ESI/Orbitrap Negative ion mode | Arachidonic Acid (20:4) | 82.1 | Peak area | Diagnosis -No treatment |
| ESI/Orbitrap Negative ion mode | Arachidonic Acid (20:4) | 84.6 | Peak area | Post remission |
| ESI/Orbitrap Negative ion mode | Arachidonic Acid (20:4) | 90.8 | Peak area | Diagnosis -No treatment |
| ESI/Orbitrap Negative ion mode | Arachidonic Acid (20:4) | 130 | Peak area | Post remission |
| ESI/Orbitrap Negative ion mode | Arachidonic Acid (20:4) | 222 | Peak area | Diagnosis -No treatment |
| ESI/Orbitrap Negative ion mode | Arachidonic Acid (20:4) | 237 | Peak area | Post remission |
| ESI/Orbitrap Negative ion mode | Arachidonic Acid (20:4) | 424 | Peak area | Diagnosis -No treatment |
| ESI/Orbitrap Negative ion mode | Arachidonic Acid (20:4) | 444 | Peak area | Diagnosis -No treatment |
| ESI/Orbitrap Negative ion mode | Arachidonic Acid (20:4) | 501 | Peak area | Diagnosis -No treatment |
| ESI/Orbitrap Negative ion mode | Arachidonic Acid (20:4) | 3970 | Peak area | Diagnosis -No treatment |
- UCSD Metabolomics Workbench, a resource sponsored by the Common Fund of the National Institutes of Health
|